342 related articles for article (PubMed ID: 26100738)
21. Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010).
DeMuro C; Clark M; Doward L; Evans E; Mordin M; Gnanasakthy A
Value Health; 2013 Dec; 16(8):1150-5. PubMed ID: 24326168
[TBL] [Abstract][Full Text] [Related]
22. Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study.
Kesselheim AS; Wang B; Franklin JM; Darrow JJ
BMJ; 2015 Sep; 351():h4633. PubMed ID: 26400751
[TBL] [Abstract][Full Text] [Related]
23. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
G de la Torre B; Albericio F
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
[TBL] [Abstract][Full Text] [Related]
24. Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug Administration.
Novack GD
Am J Ophthalmol; 2000 Nov; 130(5):664-5. PubMed ID: 11078847
[TBL] [Abstract][Full Text] [Related]
25. Mid-year at the FDA highlights permanent problem.
Howard K
Nat Rev Drug Discov; 2004 Aug; 3(8):637. PubMed ID: 15317145
[No Abstract] [Full Text] [Related]
26. FDA posts record number of drug approvals in 1996.
Am J Health Syst Pharm; 1997 Mar; 54(5):494, 497-8. PubMed ID: 9066856
[No Abstract] [Full Text] [Related]
27. The lag from FDA approval to published cost-utility evidence.
Chambers JD; Thorat T; Pyo J; Neumann PJ
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):399-402. PubMed ID: 25579324
[TBL] [Abstract][Full Text] [Related]
28. Decline in the Development of New Anesthetics.
Vlassakov KV; Kissin I
Trends Pharmacol Sci; 2016 May; 37(5):344-352. PubMed ID: 26922254
[TBL] [Abstract][Full Text] [Related]
29. An analysis of FDA-approved drugs for inflammation and autoimmune diseases.
Kinch MS; Merkel J
Drug Discov Today; 2015 Aug; 20(8):920-3. PubMed ID: 25701283
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019.
Bharate SS
Drug Discov Today; 2021 Feb; 26(2):384-398. PubMed ID: 33221522
[TBL] [Abstract][Full Text] [Related]
31. Muddied messages about FDA.
Miller HI
Nat Biotechnol; 2003 Jul; 21(7):732-3. PubMed ID: 12833084
[No Abstract] [Full Text] [Related]
32. Canadian, European and United States new drug approval times now relatively similar.
Rawson NSB
Regul Toxicol Pharmacol; 2018 Jul; 96():121-126. PubMed ID: 29730446
[TBL] [Abstract][Full Text] [Related]
33. Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases.
DiMasi JA; Florez MI; Stergiopoulos S; Peña Y; Smith Z; Wilkinson M; Getz KA
Clin Pharmacol Ther; 2020 Feb; 107(2):324-332. PubMed ID: 31502248
[TBL] [Abstract][Full Text] [Related]
34. An analysis of FDA-approved drugs for metabolic diseases.
Kinch MS; Umlauf S; Plummer M
Drug Discov Today; 2015 Jun; 20(6):648-51. PubMed ID: 25680688
[TBL] [Abstract][Full Text] [Related]
35. An overview of FDA-approved new molecular entities: 1827-2013.
Kinch MS; Haynesworth A; Kinch SL; Hoyer D
Drug Discov Today; 2014 Aug; 19(8):1033-9. PubMed ID: 24680947
[TBL] [Abstract][Full Text] [Related]
36. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495494
[TBL] [Abstract][Full Text] [Related]
37. 2017 in review: FDA approvals of new molecular entities.
Kinch MS; Griesenauer RH
Drug Discov Today; 2018 Aug; 23(8):1469-1473. PubMed ID: 29751111
[TBL] [Abstract][Full Text] [Related]
38. Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014.
Rathi VK; Wang B; Ross JS; Downing NS; Kesselheim AS; Gray ST
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):683-692. PubMed ID: 28116974
[TBL] [Abstract][Full Text] [Related]
39. An analysis of original research contributions toward FDA-approved drugs.
Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration.
Jiao K; Gupta R; Fox E; Kesselheim A; Ross JS
JAMA Netw Open; 2019 Oct; 2(10):e1913029. PubMed ID: 31603482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
